{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:27:30Z","timestamp":1786440450224,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cardfail.2025.09.017","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:09:21Z","timestamp":1759298961000},"page":"1308-1319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous Ferric Carboxymaltose in Ischemic vs Nonischemic Heart Failure and Iron Deficiency: Insights From FAIR-HF2"],"prefix":"10.1016","volume":"32","author":[{"given":"MUHAMMAD SHAHZEB","family":"KHAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAVED","family":"BUTLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAHIR","family":"KARAKAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIUS","family":"PLACZEK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GERD","family":"HASENFU\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KHAWAJA M.","family":"TALHA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANTONI","family":"BAYES-GENIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDREW J.S.","family":"COATS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL","family":"B\u00d6HM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GIUSEPPE","family":"ROSANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GIANLUIGI","family":"SAVARESE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARKUS S.","family":"ANKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PIOTR","family":"PONIKOWSKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TIM","family":"FRIEDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEFAN D.","family":"ANKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2025.09.017_bib0001","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0002","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0003","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0004","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1038\/s41591-025-03671-1","article-title":"Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency","volume":"31","author":"Anker","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0005","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0006","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S000711451900014X","article-title":"Efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a meta-analysis","volume":"121","author":"Zhang","year":"2019","journal-title":"Br J Nutr"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0007","first-page":"151","article-title":"The efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a systematic review and meta-analysis","volume":"32","author":"Qian","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003875","article-title":"Significance of ischemic heart disease in patients with heart failure and preserved, midrange, and reduced ejection fraction: a nationwide cohort study","volume":"10","author":"Vedin","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0009","first-page":"264","article-title":"Prognostic impact over time of ischaemic heart disease vs. non-ischaemic heart disease in heart failure","volume":"7","author":"Silverdal","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2016.08.316","article-title":"Mortality in systolic heart failure revisited: ischemic versus non-ischemic cardiomyopathy","volume":"224","author":"Gajanana","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0011","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0012","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/ejhf.2630","article-title":"Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial","volume":"24","author":"Metra","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0013","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0014","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","volume":"25","author":"Graham","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N Engl J Med"},{"issue":"333","key":"10.1016\/j.cardfail.2025.09.017_bib0016","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.2025.3833","article-title":"Intravenous ferric carboxymaltose in heart failure with iron deficiency: the FAIR-HF2 DZHK05 randomized clinical trial","volume":"10","author":"Anker","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0017","article-title":"Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2-DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials","author":"Anker","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0018","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/1467-9868.00259","article-title":"Semiparametric regression for the mean and rate functions of recurrent events","volume":"62","author":"Lin","year":"2000","journal-title":"J Royal Statist Soc: Series B (Statist Methodol)"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0019","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ejhf.2166","article-title":"Aetiology of heart failure is in the eye of the beholder: does it even matter?","volume":"23","author":"Khan","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","article-title":"Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF","volume":"7","author":"Balmforth","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0021","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jchf.2015.06.012","article-title":"Characteristics, Treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy","volume":"3","author":"Shore","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0022","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/eurjhf\/hfs026","article-title":"Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis","volume":"14","author":"Mart\u00ednez-Sell\u00e9s","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027652","article-title":"Impact of empagliflozin in heart failure with reduced ejection fraction in patients with ischemic versus nonischemic cause","volume":"12","author":"Khan","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0024","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ejhf.2124","article-title":"Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial","volume":"23","author":"Butt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0026","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0028","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ejhf.3574","article-title":"Rationale and design of the FAIR-HF2-DZHK05 trial: ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure","volume":"27","author":"Anker","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0029","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2025.09.017_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","article-title":"Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance","volume":"108","author":"McCrohon","year":"2003","journal-title":"Circulation"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425004282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425004282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:28:41Z","timestamp":1786436921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425004282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1071916425004282"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.09.017","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Ferric Carboxymaltose in Ischemic vs Nonischemic Heart Failure and Iron Deficiency: Insights From FAIR-HF2","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}